For example, just the combination of alanine (NMR) with clinical ALT and AST levels led to about 70% overall classification between non-NAFLD and steatosis subjects, and one additional metabolite increased overall success to about 78% (Table 5). Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.